Azelaprag

DB19329InvestigationalSmall molecule

Azelaprag is under investigation in clinical trial NCT06515418 (Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared With Tirzepatide Alone in Participants With Obesity Aged 55 Years and...

Formula / weight: C₂₅H₂₉N₇O₄S · 523.61 g/mol (avg)
Also known as: 2-pyrimidineethanesulfonamide, n-(4-(2,6-dimethoxyphenyl)-5-(5-methyl-3-pyridinyl)-4h-1,2,4-triazol-3-yl)-.alpha.,.beta.,5-trimethyl-, (.alpha.s,.beta.r)-
Code names: AMG 986 · BGE-105 · CS-0077720 · DA-50864 · HY-109111

Resolves to

Compound

UNII4B8REJ8ZGYCAS2049980-18-7ChEMBLCHEMBL4866732ChEBI758591PubChem122702529

Structure

InChIKeyDOMQFIFVDIAOOT-ROUUACIJSA-NSMILESCOC1=CC=CC(OC)=C1N1C(NS(=O)(=O)[C@@H](C)[C@H](C)C2=NC=C(C)C=N2)=NN=C1C1=CN=CC(C)=C1

Targets

P35414APLNR

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Azelaprag, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account